-
Japan approves Pfizer-BioNTech’s Covid-19 vaccine for children
Pharmaceutical-Technology
January 24, 2022
The vaccine doses that will be administered for children will use one-third of a dose given for adults.
-
Three doses of mRNA COVID vaccines very effective against Omicron and Delta: Study
ExpressPharma
January 24, 2022
The study, from the US Centers for Disease Control and Prevention (CDC), found that boosters of mRNA COVID vaccines are 82 per cent effective in protecting against Omicron variant-associated ED visits.
-
Fourth COVID vaccine partially effective against Omicron: Israeli study
ExpressPharma
January 20, 2022
A fourth dose of COVID-19 vaccine boosts antibodies to higher levels than the third jab but provides only partial protection against the Omicron variant of coronavirus, according to a preliminary study conducted in Israel.
-
Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events
WorldPharmaNews
January 20, 2022
The placebo effect is the well-known phenomenon of a person's physical or mental health improving after taking a treatment with no pharmacological therapeutic benefit - a sugar pill, or a syringe full of saline, for example.
-
WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased
drugs.com
January 19, 2022
If COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday.
-
Moderna CEO says data for Omicron-specific shot likely available in March
ExpressPharma
January 18, 2022
Moderna Inc’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks...
-
90% of Chinese people vaccinated against COVID-19
NMPA/Xinhua
January 18, 2022
Over 1.26 billion Chinese people, or nearly 90 percent of the country's population, have received COVID-19 vaccine jabs as of Friday, said a health official on Saturday.
-
Medlab receives grant to develop NanoCelle nasal vaccine for Covid-19
Pharmaceutical-Technology
January 18, 2022
The company will collaborate with the University of NSW and Macquarie University for vaccine development.
-
COVAX delivers its 1 billionth COVID-19 vaccine dose
FirstWordPharma
January 17, 2022
A shipment of 1.1 million COVID-19 vaccines to Rwanda included the billionth dose supplied via COVAX.
-
Peru urges vaccine sellers to extend expiration dates to cut risk of losses
FirstWordPharma
January 17, 2022
Peru’s Health Minister Hernando Cevallos asked companies to extend expiration dates past the current three months to reduce the risk of losing COVID-19 vaccine doses, as reported in National Post.